The authors present the unique experience of one neurovascular service under the direct supervision of the senior author, for which surgical, endovascular, and intensive care treatments were conducted in a select group of 32 patients with aneurysmal subarachnoid hemorrhage who had medically intractable symptomatic vasospasm.
She received HHH therapy because of evidence of elevated blood flow velocity detected on TCD ultrasonography posthemorrhage (PH) Day 3 (mean blood flow velocity in the right MCA increased from 96 to 161 to 224 cm/second and in the left MCA it increased from 102 to 155 to 220 on PH Day 5.) Clinically, she remained asymptomatic until PH Day 7; at which time she became diaphoretic, aphasic, and had loss of antigravity strength in the right upper extremity. The TCD ratios measured in the right MCA were 7.2 to 8.5 to 9.1 and the right MCA mean blood flow velocities were 255 cm/second; in the left MCA, TCD ratios were 3.9 to 9.3 to 8.0 and left MCA mean velocities were 207 cm/second. Her clinical status improved after receiving aggressive HHH therapy. On PH Day 9 the patient experienced a repeated episode of hemiplegia and aphasia; her mean arterial pressure was 107 to 111 mm Hg and she was treated with 250 ml 3 of 5% albumin. Strength increased to 4/5 in the right upper extremity and 3/5 in the left lower extremity. Several hours later her right side worsened to hemiplegia and aphasia. Pentobarbital was administered and emergency CT scanning was performed. Ventriculostomy and cerebral angiography were performed, which demonstrated severe bilateral vasospasm of the internal carotid arteries, and MCAs, more on the left than right. Angioplasty was performed in the left M 1 segment, supraclinoid carotid, and right supraclinoid carotid arteries (Figs. 1 lower left and right and 2 upper left). Postprocedure, the patient remained in a pentobarbital-induced coma for 3 days, which was progressively decreased by 25% each postprocedure day. Transcranial Doppler ultrasonography was performed postprocedure. On postoperative Day 1, TCD ratios were: left MCA 2.3 (mean MCA velocity 88 cm/second) and right MCA 3.1 (mean MCA velocity 136 cm/second). Over the following 7 days the right-sided TCD ratios progressively increased. The patient did not tolerate HHH therapy, with decreased cardiac contractility (cardiac ejection fraction 57-35%). On PH Day 23, repeated angiography was performed because the patient was not tolerating HHH therapy and had persistent right MCA ratios of between 5 and 7. Angioplasty was performed in the stenotic right M 1 segment (Fig. 2 upper right and lower left and right). Comorbidity features included acute lung injury with pneumonia, pulmonary edema, decreased cardiac contractility, and inflammatory arthritis of the right foot/ankle/toe. The patient's cardiac dysfunction resolved after discontinuation of HHH therapy. She was progressively weaned, extubated, and discharged home for outpatient rehabilitation. Currently, the patient lives at home and has returned to work at her 3-month follow up.
Case 24
This 38-year-old woman presented with Hunt and Hess Grade IV SAH from a ruptured left MCA aneurysm, as well as with sylvian fissure hematoma and hydrocephalus (Fig. 3 A-B) . On admission, she underwent intubatation, was experiencing contralateral hemiparesis, and also underwent a ventriculostomy. A left frontotemporal craniotomy and microsurgical clipping of the left MCA aneurysm were performed. Intraoperative angiography confirmed aneurysm clipping and normal filling of the superior and inferior trunks (Fig. 3C ). Due to significant cerebral edema, pentobarbital therapy was initiated; the bone flap was left out and the dura left open. The patient remained in a pentobarbital-induced coma and ICP was controlled using ventricular drainage. On postoperative Day 3, she developed hypoxia and required increased positive end-expiratory pressure, fraction of inspired oxygen, and aggressive pulmonary toilet. There was evidence of early pancreatitis with pleural effusion and hypoxia on postoperative Day 4, and the patient was continued on bowel rest with hyperalimentation via total parenteral nutrition. On postoperative Day 6 she developed increased ICP to 22 mm Hg and increased cerebrospinal fluid output. Computerized tomography scanning revealed no new hemorrhage or ventriculomegaly. Transcranial Doppler ultrasonography demonstrated increased right-sided velocities from means of 130 to 160 cm/second with ratios increased from 2.0 to 5.0 on the right. Her pulmonary insufficiency was worsening, and an x-ray film of the chest demonstrated lobar collapse with pneumonia ( Fig. 3D ). Subsequently, she underwent emergency bronchoscopy and tracheostomy (Fig. 3E ). On PH Day 10, while receiving pentobarbital therapy, she had significantly elevated blood flow ratios, which increased from 3.9 to 7.9 on the right and from 3.2 to 4.1 on the left; mean right MCA velocities increased from 138 to 205 cm/second and then to 220 cm/second. Angiography was performed, which revealed evidence of vasospasm of the bilateral M 1 segment (Fig. 3F ). She underwent angioplasty (Fig. 3 F-G); postangioplasty her TCD measurements showed a reduced mean right MCA velocity of 143 cm/second and a left MCA velocity of 112 cm/second; a mean right MCA ratio of 4.9 and left MCA ratio of 2.0. Pentobarbital therapy was progressively decreased over the next 5 days, with improved pulmonary toilet, aggressive chest physiotherapy and nebulizers. Subsequently, she was discharged to inpatient rehabilitation.
Progressive improvement was noted at 6-week and 12-week follow-up examination. Currently, she is doing well at 10 months postoperatively and her autologous bone flap was replaced. She has no focal neurological deficits and has returned to a regular work schedule.
Case 22
The patient was a 42-year-old male jockey, who suffered SAH while riding his horse. He fell to the ground and experienced a seizure, respiratory arrest, and had a likely aspiration. He was resuscitated and remained unresponsive in a coma at initial assessment (Hunt and Hess Grade V). Computerized tomography scanning of the head demonstrated evidence of diffuse SAH, hydrocephalus, and a 3.5-cm mass revealed as the giant aneurysm (Fig. 4A) . Angiography confirmed a giant left supraclinoid artery aneurysm (Fig. 4B) . Ventriculostomy was placed, and his neurological status improved to a Hunt and Hess Grade IV. Due to pulmonary aspiration, he developed pneumonia and subsequently adult respiratory distress syndrome (ARDS), requiring pressure-controlled ventilation. On PH Day 4, he had a significant increase in his TCD measurement, increased CSF drainage via his ventriculostomy and elevated ICP to 20 mm Hg. The TCD values increased from PH Day 3 to PH Day 5 (right MCA mean velocities of 83 to 151 to 183 to 227 to 255 cm/second and left MCA mean velocities 133 to 200 cm/second); over the same period TCD ratios increased (right 3.3-10.3; left 5.2-13.3). Repeated angiography confirmed severe bilateral vasospasm of both M 1 vessels and the supraclinoid carotid artery, as well as of the bilateral A 1 segments. Because of the presence of an untreated ruptured giant aneurysm, he was not a candidate for angioplasty or papaverine therapy. He was placed in pentobarbital-induced coma and aggressively treated for his aspiration pneumonia and ARDS. Tracheostomy and bronchoscopy were performed to improve oxygenation and pulmonary toilet. Moderate HHH therapy was continued as tolerated. On PH Day 8, endovascular exploration of the aneurysm was performed, which demonstrated a small-neck aneurysm that made GDC treatment of the aneurysm possible (Fig. 4C-E) . Attempts to perform angioplasty in the left M 1 segment were thwarted by the mass effect from the giant aneurysm fundus. The patient was progressively weaned from his pressure-support
Case 26
This 33-year-old man presented with a Hunt and Hess Grade V SAH resulting from rupture of a basilar bifurcation aneurysm (Fig. 5A-B) . The patient improved to Grade IV following placement of a ventriculostomy. Because of increased ICP, a CT scan was obtained, which demonstrated evidence of new hemorrhage into the cerebral peduncle. The patient had progressive pulmonary distress with oxygen desaturation and underwent emergency bronchoscopy for lobar collapse. Posthemorrhage Day 3, he underwent GDC treatment of the aneurysm, with balloon remodeling techniques (Fig. 5C-D) . Elevated TCD values were noted on PH Day 3. He underwent balloon angioplasty of the anterior circulation and was placed in pentobarbital-induced coma. Posthemorrhage Day 8, he had SjVO 2 changes that demonstrated increased oxygen extraction consistent with an oligemic state. Posterior circulation TCD values were elevated; a repeated CT scan was obtained that revealed bilateral hypodensities of the PCAs. A cerebral angiogram demonstrated an occluded right vertebral artery (Fig. 5E ). Emergency vertebral artery angioplasty with stent placement was performed, followed by basilar artery angioplasty (Fig. 5F-G) . His course was complicated by pneumonia, sepsis, pancreatitis, and prolonged intubation. He underwent placement of a ventriculoperitoneal shunt and, following a prolonged intensive care unit course, he was transferred to rehabilitation. At 3-month follow-up review he had recovered substantially; he was living independently and was cutting his lawn and cleaning the family swimming pool.
RESULTS
Twenty-one patients survived and 11 died after undergoing treatment using this protocol (Table 1) ; associated morbidity factors included pneumonia with acute lung injury (18 patients) and fulminant ARDS (six patients), sepsis (16 patients), pancreatitis (five patients), cardiac dysfunction (three patients), and septic arthritis and pulmonary embolus (one patient each). Infectious complications were monitored by closely following the differential white-cell count, early use of tracheostomy and aggressive pulmonary toilet (Case 24). Of the 21 survivors, seven have returned to work, live independently, and have no neurological deficits; eight require mild assistance at home; four are in rehabilitation and have moderate deficits at 3 months; and two remain in a vegetative state. Factors associated with a poor outcome include a delay of more than 2 hours in recognition or intervention for vasospasm (Cases 8, 9, and 16; Table 1 ), associated morbidity factors related to preexisting medical condition combined with pentobarbital therapy (Case 21), branch occlusion with vessel rupture (Case 13), and intractable ICP related to small-vessel vasospasm (Cases 14 and 15) . In a selected group of poor-grade patients, a single cause could not be identified and was likely related to the patient's poor clinical grade (Cases 18 and 19) .
DISCUSSION
The common goal in treating vasospasm in patients with symptomatic SAH involves minimizing the neuronal injury. Approaches are directed toward two major avenues, including improving cerebral blood flow (CBF) as well as reducing cellular energy demands, thereby avoiding a demand/supply mismatch that results in irreversible neuronal injury. [2] Improving CBF is accomplished by a host of different techniques, including standard HHH therapy, ventricular drainage, and more novel invasive techniques that include removal of the craniotomy flap, as well as cerebral angioplasty. Cellular energy demands are minimized during periods of oligemia by hypothermia, seizure prophylaxis, and avoiding hypoxia, acidosis, and hyperglycemia as well as providing neuroprotection.
It is important to note that standard HHH therapy is not without risk, as demonstrated by patients in Cases 20 and 21. Authors of other studies have reported complication rates of pulmonary edema (7-17%), myocardial infarction (2%), coagulopathy (3%), and dilutional hyponatremia (3-35%). [8, 9] Because of underlying cardiac dysfunction, neither of these two patients (Cases 20 and 21) tolerated HHH therapy. The patient in Case 20 developed severe loss of cardiac contractility amd rapidly developed cardiac failure at low-filling pressures. The patient in Case 21 sustained a myocardial infarction resulting in electromechanical dissociation and death. When faced with a patient with both poor cardiac function and advanced age, it may be necessary to consider a less toxic therapy than HHH treatment and avoid pentobarbital therapy unless an absolutely life-threatening condition exists. It is also well reported that poor-grade SAH patients have a higher incidence of acute lung injury. [5] The modalities used to treat pulmonary insufficiency may also compromise the treatment of vasospasm (Table 3) .
Currently, our trend is toward early performance of angioplasty and use of pentobarbital therapy only when distal spasm predominates in the face of elevated ICP.
Pentobarbital therapy is only one aspect used in the emergency treatment response to symptomatic medically intractable vasospasm. Its use includes rapidly coordinated and rehearsed protocols for restoring CBF. Pentobarbital not only reduces cerebral metabolic oxygen rate [2] until electrical silence is obtained (equating with a 50% decrease in cerebral metabolic oxygen rate), but also enhances the binding of gamma-aminobutyric acid, an inhibitory neurotransmitter, thereby reducing excitotoxicity and increased energy expenditure. [1, 4, 6, 7, 9, 12, 14, 15] One of the most important modes of action of pentobarbital is as a free radical scavenger that reduces the lipid peroxidation of the neuronal cell membrane and intracellular organelles. [10, 11] Experience with combined endovascular therapy and pentobarbital is limited. In a recent study, [4] 18 patients with medically intractable vasospasm who underwent endovascular therapy were divided into two equal groups; one group was treated with combined therapy using thiopental, whereas the other group only underwent endovascular therapy. A more favorable outcome was seen in the barbiturate adjunctive group in which five of nine improved to good recovery; one had mild deficit, and one died. These patients also underwent jugular-bulb monitoring, with subsequent improvement in the arteriovenous lactate difference and in cerebral oxygen extraction with restoration of normal coupling of CBF and oxygen consumption. In the control arm, two of nine patients had good recovery, two had mild deficit, four had severe deficit, and one died. The authors concluded that this protocol should be used as a last-line therapy for intractable vasospasm. [4] Timing and indications for barbiturate protection remain controversial. Proponents of barbiturate protection agree that best results are achieved when burst suppression occurs prior to the ischemic insult. This is not practical for the unpredictable nature of vasospasm. However, it is agreed that beyond 3 hours a deleterious effect is noted in experimental models. [10, 11, 16] Barbiturate therapy may be replaced by early use of pentobarbital in the face of intractable vasospasm, especially when accompanied by increased ICP or distal spasm not likely to respond to proximal angioplasty. Our results support early (< 2 hours) initiation of pentobarbital therapy before a deficit becomes irreversible.
The neurovascular uses of pentobarbital have included neuroprotection during temporary aneurysm clipping, carotid endarterectomy, hypothermic cardiac arrest, and vascular bypass surgery. Early experience with pentobarbital therapy for the treatment of vasospasm produced poor results. Kassell, et al., [8] have reported on 12 patients who were treated with high-dose pentobarbital; three of these patients initially benefited, although two of them eventually died, and nine additional patients died as well. The surviving patient was left with paraparesis. Other experiences with pentobarbital therapy and vasospasm are summarized in Table 4 . These experiences all have a common element: neuronal protection was established without restoration of CBF. Our experience has differed because of the two-pronged attack to restore CBF and protect the compromised neuronal pool. Integrating reduction of ICP (ventriculostomy and craniectomy) and restoring CBF with angioplasty has resulted in a successful neurological rescue; the lives of 21 of 32 patients have been saved and, most importantly, seven of these 21 patients have returned to independent living; only eight patients require minimal assistance with daily activities, and four patients are moderately disabled at less than 3 months posthemorrhage. We are encouraged by these results, but we also feel remiss about the two patients who remain vegetative survivors. Their tremendous loss in quality of life and their emotional, financial, and personal devastation have driven us to seek new means to improve outcome with earlier therapies and to pursue new treatment modalities.
The early use of cerebral angioplasty has provided tremendous gains in the treatment of delayed cerebral vasospasm when it involves proximal cerebral arteries. Eskridge and Song [3] reported the use of balloon angioplasty in more than 150 patients who were typically treated within a time window of 12 to 18 hours. In a selected group of 52 patients, they identified the superior results of balloon angioplasty when compared with papaverine therapy; 39 patients underwent angioplasty and 13 papaverine therapy. Only one vessel of 101 treated in the angioplasty group required retreatment with balloon angioplasty, whereas in the papaverine group 42% required retreatment. The time period for intervention and the pattern of vasospasm (proximal, distal, diffuse) was not specified. In a study of 93 patients who underwent angioplasty, Rosenwasser and coworkers (unpublished data), reported a 70% sustained clinical improvement in 51 patients treated within 2 hours but only a 40% sustained improvement in 33 patients treated after 2 hours. Time and location of spasm play a key role in determining the likelihood of response to endovascular techniques. Distal spasm is the most recalcitrant to endovascular treatment. Although balloon angioplasty is effective in dilating the proximal arteries, papaverine therapy used for distal spasm has a very short half-life, requiring frequent retreatment. The hazards of papaverine therapy are numerous, including crystalization, hypotension, intractable ICP, and hemorrhagic transformation of cerebral infarctions. Currently, no single agent is effective at long-term reversal of distal vasospasm, although there are several agents on the horizon awaiting clinical trials to prove their effectiveness (unpublished data)
In the battle against vasospasm, a rapid, coordinated intervention to protect the neuronal pool and restore blood flow must occur if worthwhile survival is to be attained. Ultimately, the lessons learned from earlier use of pentobarbital therapy demonstrated that when used alone it is not the solution. Restoring CBF and reducing ICP must occur in tandem before a completed infarct occurs. Pulmonary and cardiac complications associated with pentobarbital use should be anticipated and cardiopulmonary function should be optimized with oximetric Swan-Ganz monitoring and early tracheostomy and bronchoscopy for pulmonary toilet. Our experience does support the tailored use of pentobarbital therapy combined with CBF restoration. Despite the best equipment, medicines and expertise, one must race against the clock to salvage an ischemic neuronal pool and avoid the tragedy of patients enduring in vegetative state.
